How often is ecnoglutide taken?
Ecnoglutide is a novel, long-acting GLP-1 receptor agonist currently in clinical trials looking at its safety and efficacy in treating obesity and type 2 diabetes. It is expected to be a once weekly injection whenever it comes on the market, due to its long half-life that ranges from 124 to 138 hours. Clinical trials with ecnoglutide have looked at various doses (e.g., 0.4 mg, 0.8 mg, 1.2 mg, 1.8 mg, and 2.4 mg) given as subcutaneous injections once a week.
Shop Medications
Why Pay Full Price?
Search our full medication catalogue and save up to 80% - no insurance needed.
See Prices Now